Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
Subtitle: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012
Publisher: U.S. Government Printing Office
Published: 2013
Place of publication: Washington
Language: eng
Number of pages: 194
Subjects: Drug approval; Generic drugs; Government policy; Biologicals; Drug accessibility; Administrative Fees; Rules and practice; United States. Food and Drug Administration; United States
Notes: Shipping list no.: 2013-0316-P.

"Serial no. 112-114."

Includes bibliographical references.